Climb Bio (CLYM) Other Accumulated Expenses (2021 - 2026)

Climb Bio (CLYM) has 5 years of Other Accumulated Expenses data on file, last reported at $113000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 88.7% year-over-year to $113000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113000.0 (down 88.7% YoY) and the FY2025 annual result came in at $59000.0, down 33.71% from the prior year.
• Other Accumulated Expenses advanced to $113000.0 in Q1 2026, from $59000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.3 million in Q2 2024 to a low of $22000.0 in Q3 2024.
• A 4-year average of $312200.0 and a median of $101000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 250.0% in 2025, down 97.12% in 2025.
• Tracing CLYM's Other Accumulated Expenses over 4 years: stood at $138000.0 in 2023, then slumped by 35.51% to $89000.0 in 2024, then sank by 33.71% to $59000.0 in 2025, then surged by 91.53% to $113000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $113000.0 (Q1 2026), $59000.0 (Q4 2025), and $77000.0 (Q3 2025), per Business Quant data.